203 related articles for article (PubMed ID: 3610256)
1. Structure and expression of HLA-DQ alpha and -DX alpha genes: interallelic alternate splicing of the HLA-DQ alpha gene and functional splicing of the HLA-DQ alpha gene using a retroviral vector.
Auffray C; Lillie JW; Korman AJ; Boss JM; Fréchin N; Guillemot F; Cooper J; Mulligan RC; Strominger JL
Immunogenetics; 1987; 26(1-2):63-73. PubMed ID: 3610256
[TBL] [Abstract][Full Text] [Related]
2. RFLP of the HLA-DQ alpha region: a diallelic DX alpha polymorphism, not linked to DR and DQ specificities.
Tilanus MG; Van Eggermond MC; Fei H; D'Amaro J; Schreuder GM; Giphart MJ
Tissue Antigens; 1987 Sep; 30(3):128-34. PubMed ID: 2892281
[TBL] [Abstract][Full Text] [Related]
3. Specific allelic variation among linked HLA class II genes.
Amar A; Holbeck SL; Nepom GT
Transplantation; 1987 Dec; 44(6):831-5. PubMed ID: 2892292
[TBL] [Abstract][Full Text] [Related]
4. Genetic complexity and expression of human class II histocompatibility antigens.
Korman AJ; Boss JM; Spies T; Sorrentino R; Okada K; Strominger JL
Immunol Rev; 1985 Jul; 85():45-86. PubMed ID: 3899915
[TBL] [Abstract][Full Text] [Related]
5. Class II genes of the human major histocompatibility complex. Comparisons of the DQ and DX alpha and beta genes.
Jonsson AK; Hyldig-Nielsen JJ; Servenius B; Larhammar D; Andersson G; Jörgensen F; Peterson PA; Rask L
J Biol Chem; 1987 Jun; 262(18):8767-77. PubMed ID: 3036828
[TBL] [Abstract][Full Text] [Related]
6. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
7. Relationship between DQ alpha and DQ beta RFLP and cell surface polymorphisms of class II HLA antigens.
Cascino I; Rosenshine S; Turco E; Marrari M; Duquesnoy RJ; Trucco M
J Immunogenet; 1986; 13(5-6):387-400. PubMed ID: 2887620
[TBL] [Abstract][Full Text] [Related]
8. Identification with the monoclonal antibody 26.163 of a determinant shared by the beta chains of the gene products of the HLA-DR, DQ, and DP loci.
Igarashi M; Gebhard DH; Chen YX; Safai B; Evans RL; Ferrone S
Hum Immunol; 1986 Aug; 16(4):347-55. PubMed ID: 2428781
[TBL] [Abstract][Full Text] [Related]
9. Mapping of the HLA-D region by pulsed-field gel electrophoresis: size variation in the DQ-DR interval.
Inoko H; Ando A; Tsuji K
Tokai J Exp Clin Med; 1990 May; 15(2-3):253-60. PubMed ID: 2130532
[TBL] [Abstract][Full Text] [Related]
10. Structural analysis of the HLA-DR, -DQ, and -DP alleles on the celiac disease-associated HLA-DR3 (DRw17) haplotype.
Kagnoff MF; Harwood JI; Bugawan TL; Erlich HA
Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6274-8. PubMed ID: 2788285
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a specific post-transcriptional mechanism controlling the expression of HLA-DQ, but not -DR and -DP, molecules.
De Lerma Barbaro A; Sartoris S; Tosi G; Nicolis M; Accolla RS
J Immunol; 1994 Nov; 153(10):4530-8. PubMed ID: 7525708
[TBL] [Abstract][Full Text] [Related]
12. HLA-DR, DQ, and DX alpha RFLPs and their associations with serologically defined HLA-DR and -DQ antigens.
Awad J; Navarrete C; Sachs JA; Festenstein H; Cassell PG; Niven MJ; Hitman G
Immunogenetics; 1988; 27(1):73-6. PubMed ID: 2890578
[No Abstract] [Full Text] [Related]
13. Differential expression of related HLA class II DQ beta genes caused by nucleotide variation in transcriptional regulatory elements.
Shewey LM; Beaty JS; Andersen LC; Nepom GT
J Immunol; 1992 Feb; 148(4):1265-73. PubMed ID: 1737939
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional enhancers in the HLA-DQ subregion.
Sullivan KE; Peterlin BM
Mol Cell Biol; 1987 Sep; 7(9):3315-9. PubMed ID: 3118196
[TBL] [Abstract][Full Text] [Related]
15. An isotype-specific trans-acting factor is defective in a mutant B cell line that expresses HLA-DQ, but not -DR or -DP.
Ono SJ; Bazil V; Sugawara M; Strominger JL
J Exp Med; 1991 Mar; 173(3):629-37. PubMed ID: 1997650
[TBL] [Abstract][Full Text] [Related]
16. DQw1 beta gene from HLA-DR2-Dw12 consists of six exons and expresses multiple DQw1 beta polypeptides through alternative splicing.
Tsukamoto K; Yasunami M; Kimura A; Inoko H; Ando A; Hirose T; Inayama S; Sasazuki T
Immunogenetics; 1987; 25(5):343-6. PubMed ID: 3494674
[No Abstract] [Full Text] [Related]
17. Evidence for a lymphocyte activation determinant coded by the HLA region different from HLA-DR, DQ, and DP.
Eiermann TH; Martin A; Wölpl A; Goldmann SF
Transplant Proc; 1987 Feb; 19(1 Pt 1):866-9. PubMed ID: 3824496
[No Abstract] [Full Text] [Related]
18. Molecular organization of the DQ subregion (DO-DX-DV-DQ) of the human MHC and its evolutionary implications.
Blanck G; Strominger JL
J Immunol; 1988 Sep; 141(5):1734-7. PubMed ID: 3411129
[TBL] [Abstract][Full Text] [Related]
19. A combination of a particular HLA-DP beta allele and an HLA-DQ heterodimer confers susceptibility to coeliac disease.
Bugawan TL; Angelini G; Larrick J; Auricchio S; Ferrara GB; Erlich HA
Nature; 1989 Jun; 339(6224):470-3. PubMed ID: 2498667
[TBL] [Abstract][Full Text] [Related]
20. HLA DQA1 genes generate multiple transcripts by alternative splicing and polyadenylation of the 3' untranslated region.
Hoarau JJ; Cesari M; Caillens H; Cadet F; Pabion M
Tissue Antigens; 2004 Jan; 63(1):58-71. PubMed ID: 14651525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
